We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
237 hedge funds and large institutions have $6.73B invested in Alnylam Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 106 increasing their positions, 59 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
114% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 22
80% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 59
33% more call options, than puts
Call options by funds: $84.9M | Put options by funds: $63.7M
20% more funds holding in top 10
Funds holding in top 10: 10 → 12 (+2)
20% more capital invested
Capital invested by funds: $5.62B → $6.73B (+$1.11B)
10% more funds holding
Funds holding: 215 → 237 (+22)
Holders
237
Holders Change
+22
Holders Change %
+10.23%
% of All Funds
6.32%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.32%
New
47
Increased
106
Reduced
59
Closed
22
Calls
$84.9M
Puts
$63.7M
Net Calls
+$21.2M
Net Calls Change
+$5.1M
Top Buyers
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$103M |
| 2 |
AWG
Alpha Wave Global
New York
|
-$50.3M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$20.5M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$20.2M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$16.5M |
